| Product Code: ETC4694548 | Publication Date: Nov 2023 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Radiopharmaceutical Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Radiopharmaceutical Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Radiopharmaceutical Market - Industry Life Cycle |
3.4 Ireland Radiopharmaceutical Market - Porter's Five Forces |
3.5 Ireland Radiopharmaceutical Market Revenues & Volume Share Segmentations, 2021 & 2031F |
3.6 Ireland Radiopharmaceutical Market Revenues & Volume Share, By Applications, 2021 & 2031F |
3.7 Ireland Radiopharmaceutical Market Revenues & Volume Share, By Procedural Volume Assessment, 2021 & 2031F |
3.8 Ireland Radiopharmaceutical Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.9 Ireland Radiopharmaceutical Market Revenues & Volume Share, By End-users, 2021 & 2031F |
4 Ireland Radiopharmaceutical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Ireland Radiopharmaceutical Market Trends |
6 Ireland Radiopharmaceutical Market Segmentations |
6.1 Ireland Radiopharmaceutical Market Segmentations |
6.1.1 Overview and Analysis |
6.1.2 Ireland Radiopharmaceutical Market Revenues & Volume, By Diagnostic Nuclear Medicine, 2021-2031F |
6.1.3 Ireland Radiopharmaceutical Market Revenues & Volume, By Therapeutic Nuclear Medicine, 2021-2031F |
6.2 Ireland Radiopharmaceutical Market, By Applications |
6.2.1 Overview and Analysis |
6.2.2 Ireland Radiopharmaceutical Market Revenues & Volume, By Diagnostic Applications, 2021-2031F |
6.2.3 Ireland Radiopharmaceutical Market Revenues & Volume, By Therapeutic Applications, 2021-2031F |
6.3 Ireland Radiopharmaceutical Market, By Procedural Volume Assessment |
6.3.1 Overview and Analysis |
6.3.2 Ireland Radiopharmaceutical Market Revenues & Volume, By Diagnostic Procedures, 2021-2031F |
6.3.3 Ireland Radiopharmaceutical Market Revenues & Volume, By Therapeutic Procedures, 2021-2031F |
6.4 Ireland Radiopharmaceutical Market, By Source |
6.4.1 Overview and Analysis |
6.4.2 Ireland Radiopharmaceutical Market Revenues & Volume, By Nuclear Reactors, 2021-2031F |
6.4.3 Ireland Radiopharmaceutical Market Revenues & Volume, By Cyclotrons, 2021-2031F |
6.5 Ireland Radiopharmaceutical Market, By End-users |
6.5.1 Overview and Analysis |
6.5.2 Ireland Radiopharmaceutical Market Revenues & Volume, By Hospitals, 2021-2031F |
6.5.3 Ireland Radiopharmaceutical Market Revenues & Volume, By Ambulatory Surgical Centers, 2021-2031F |
6.5.4 Ireland Radiopharmaceutical Market Revenues & Volume, By Diagnostic Centers, 2021-2031F |
6.5.5 Ireland Radiopharmaceutical Market Revenues & Volume, By Cancer Research Institutes, 2021-2031F |
6.5.6 Ireland Radiopharmaceutical Market Revenues & Volume, By Others, 2021-2031F |
7 Ireland Radiopharmaceutical Market Import-Export Trade Statistics |
7.1 Ireland Radiopharmaceutical Market Export to Major Countries |
7.2 Ireland Radiopharmaceutical Market Imports from Major Countries |
8 Ireland Radiopharmaceutical Market Key Performance Indicators |
9 Ireland Radiopharmaceutical Market - Opportunity Assessment |
9.1 Ireland Radiopharmaceutical Market Opportunity Assessment Segmentations, 2021 & 2031F |
9.2 Ireland Radiopharmaceutical Market Opportunity Assessment, By Applications, 2021 & 2031F |
9.3 Ireland Radiopharmaceutical Market Opportunity Assessment, By Procedural Volume Assessment, 2021 & 2031F |
9.4 Ireland Radiopharmaceutical Market Opportunity Assessment, By Source, 2021 & 2031F |
9.5 Ireland Radiopharmaceutical Market Opportunity Assessment, By End-users, 2021 & 2031F |
10 Ireland Radiopharmaceutical Market - Competitive Landscape |
10.1 Ireland Radiopharmaceutical Market Revenue Share, By Companies, 2024 |
10.2 Ireland Radiopharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here